Elutia (ELUT) News Today → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free ELUT Stock Alerts $3.31 +0.09 (+2.80%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14, 2024 | americanbankingnews.comCantor Fitzgerald Trims Elutia (NASDAQ:ELUT) Target Price to $5.00May 13, 2024 | finance.yahoo.comElutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024May 10, 2024 | marketbeat.comElutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor FitzgeraldCantor Fitzgerald cut their price objective on Elutia from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Friday.May 10, 2024 | investorplace.comELUT Stock Earnings: Elutia Misses EPS, Beats Revenue for Q1 2024May 9, 2024 | finance.yahoo.comElutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceMay 2, 2024 | finance.yahoo.comElutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024April 24, 2024 | globenewswire.comElutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1April 13, 2024 | marketbeat.comElutia Inc. (NASDAQ:ELUT) Short Interest UpdateElutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 17,000 shares, an increase of 32.8% from the March 15th total of 12,800 shares. Based on an average trading volume of 21,200 shares, the short-interest ratio is presently 0.8 days. Approximately 0.1% of the shares of the company are sold short.March 28, 2024 | marketbeat.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 43.1%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 12,800 shares, a decrease of 43.1% from the February 29th total of 22,500 shares. Based on an average daily trading volume, of 25,900 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the shares of the company are sold short.March 10, 2024 | finanznachrichten.deElutia Inc.: Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM Clearance Decision in First Half of 2024March 10, 2024 | finance.yahoo.comElutia Full Year 2023 Earnings: Misses ExpectationsMarch 8, 2024 | finance.yahoo.comQ4 2023 Elutia Inc Earnings CallMarch 7, 2024 | investorplace.comELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q4 2023March 7, 2024 | benzinga.comRecap: Elutia Q4 EarningsMarch 7, 2024 | globenewswire.comElutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024March 6, 2024 | benzinga.comPreview: Elutia's EarningsFebruary 22, 2024 | globenewswire.comElutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024February 22, 2024 | finance.yahoo.comUmoja Biopharma to Participate in a Fireside Chat at the Evercore ISI 2024 Emerging Biotech ConferenceFebruary 21, 2024 | finance.yahoo.comCalliditas Year-end report, January - December 2023February 11, 2024 | wsj.comElutia Inc.February 9, 2024 | proactiveinvestors.comElutia's CanGarooRM: Pioneering Drug-Eluting Biologic for Secure Medical ImplantsFebruary 9, 2024 | marketbeat.comElutia (NASDAQ:ELUT) Trading Down 1.2%Elutia (NASDAQ:ELUT) Shares Down 1.2%February 4, 2024 | msn.comAziyo Biologics Announces Executive Compensation AdjustmentsJanuary 11, 2024 | finanznachrichten.deElutia Inc.: Elutia Regains Compliance with Nasdaq Listing RequirementsJanuary 10, 2024 | msn.comElutia regains compliance with NasdaqJanuary 10, 2024 | finance.yahoo.comElutia Regains Compliance with Nasdaq Listing RequirementsJanuary 10, 2024 | finance.yahoo.comElutia Inc. (ELUT) Stock Historical Prices & Data - Yahoo FinanceJanuary 2, 2024 | bizjournals.comSilver Spring regenerative medicine firm Elutia regains Nasdaq compliance as business prospects brightenDecember 18, 2023 | finance.yahoo.comElutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA ClearanceNovember 20, 2023 | msn.comElutia files to sell 18.58M shares of Class A common stock for holdersNovember 17, 2023 | msn.comElutia Inc. (ELUT) Upgraded to Buy: Here's WhyNovember 14, 2023 | markets.businessinsider.comWhere Elutia Stands With AnalystsNovember 13, 2023 | benzinga.comElutia: Q3 Earnings InsightsNovember 10, 2023 | benzinga.comEarnings Outlook For ElutiaNovember 9, 2023 | finanznachrichten.deElutia Inc.: Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNovember 9, 2023 | finance.yahoo.comElutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionNovember 6, 2023 | finance.yahoo.comElutia to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023September 20, 2023 | finance.yahoo.comElutia to Participate in a Panel Discussion at the Cantor Global Healthcare ConferenceSeptember 19, 2023 | morningstar.comElutia Inc Ordinary Shares - Class ASeptember 19, 2023 | msn.comWhy Is Biologics-Focused Elutia Stock Trading Higher Today?September 19, 2023 | msn.comBerkeley Biologics to acquire Elutia’s Orthobiologics business unitSeptember 19, 2023 | msn.comElutia to raise up to $26.2M via private placement offeringsSeptember 19, 2023 | finance.yahoo.comElutia Announces Private Placement for Proceeds Up to $26 MillionSeptember 18, 2023 | marketwatch.comElutia Shares Jump 44% After Selling Orthobiologics BusinessSeptember 18, 2023 | marketwatch.comStocks to Watch: Elutia, 60 Degrees Pharmaceuticals, Equinox GoldSeptember 18, 2023 | finance.yahoo.comElutia Announces Sale of Orthobiologics Business Unit for Cash Proceeds of Up to $35 MillionSeptember 8, 2023 | finance.yahoo.comElutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 7, 2023 | bizjournals.comMaryland's Aziyo Biologics rebrands amid big changesSeptember 7, 2023 | finance.yahoo.comSilver Spring's Aziyo Biologics is now ElutiaSeptember 7, 2023 | finanznachrichten.deAziyo Biologics Announces Publication of a CanGaroo Case Study Demonstrating Bioenvelope Benefits for Reoperative Procedures Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (Ad)Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. ELUT Media Mentions By Week ELUT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELUT News Sentiment▼-0.330.43▲Average Medical News Sentiment ELUT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELUT Articles This Week▼31▲ELUT Articles Average Week Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PLX News Today ATHA News Today CGTX News Today CVM News Today GRTS News Today TIL News Today DTIL News Today TSBX News Today ALVR News Today PASG News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELUT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
